Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shaima'a Hamarsheh"'
Autor:
Shaima'a Hamarsheh, Robert Zeiser
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Inflammation is involved in tumor development and progression as well as antitumor response to therapy. In the past decade, the crosstalk between inflammation, immunity, and cancer has been investigated extensively, which led to the identification of
Externí odkaz:
https://doaj.org/article/5665d2d98e3749b2aa9a53010fce210c
Autor:
Shaima’a Hamarsheh, Justus Duyster, Lukas Braun, Franziska M. Uhl, Sandra Duquesne, Geoffroy Andrieux, Robert Zeiser, Melanie Boerries, Annette Schmitt-Graeff, Lena Osswald, Christine Dierks, Tilman Brummer, Claudius Klein
Publikováno v:
Molecular Cancer Research. 19:1596-1608
The bone marrow microenvironment (BMME) is key player in regulation and maintenance of hematopoiesis. Oncogenic RAS mutations, causing constitutive activation of multiple tumor-promoting pathways, are frequently found in human cancer. So far in hemat
Autor:
Savita Bisht, Stefano Ricagno, Heiko Bruns, Mario M. Zaiss, Shaima’a Hamarsheh, Andreas Mackensen, Christian Bach, Martin Eberhardt, Dimitrios Mougiakakos, Luca Broggini, Simon Völkl, Martin Böttcher, Jens Nolting, Daniel Hofbauer, Maike Büttner-Herold, Fabio Moda, Chiara De Luca, Katrin Bitterer, Robert Zeiser, Julio Vera, Frank Neumann
Publikováno v:
SSRN Electronic Journal.
As significant constituents of the tumor microenvironment in multiple Myeloma (MM), pro-inflammatory macrophages are key promoters of disease progression, bone destruction, and immune-impairment. Consequently, the identification of endogenous mediato
Autor:
Franziska M. Uhl, Dietmar Pfeifer, Melanie Boerries, Donatella De Feo, Shaima’a Hamarsheh, Heiko Becker, Benedikt S. Saller, Lena Osswald, Claudia Lengerke, Janaki Manoja Vinnakota, Miriam Erlacher, Geoffroy Andrieux, Justus Duyster, Sandra Duquesne, Robert Zeiser, Martina Konantz, Mark E. Cooper, Annette Schmitt-Graeff, Tilman Brummer, Christoph Schürch, Charlotte M. Niemeyer, Nils Venhoff, Olaf Groß, Michael Lübbert, Khalid Shoumariyeh, Burkhard Becher, Susanne Unger, Bruce R. Blazar
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-17 (2020)
Nature Communications
Nature Communications
Oncogenic Ras mutations occur in various leukemias. It was unclear if, besides the direct transforming effect via constant RAS/MEK/ERK signaling, an inflammation-related effect of KRAS contributes to the disease. Here, we identify a functional link b
Autor:
Heiko Bruns, Stefano Ricagno, Cindy Flamann, Shaima’a Hamarsheh, Frank Neumann, Andreas Mackensen, Katrin Bitterer, Maike Büttner-Herold, Cristina Visentin, Robert Zeiser, Christian Bach, Dimitrios Mougiakakos, Stefan Haskamp, Daniel Hofbauer, Martin Böttcher, Savita Bisht, Chiara De Luca, Fabio Moda, Martin Eberhardt, Luca Broggini, Bernd M. Spriewald, Julio Vera, Mario M. Zaiss, Jens Nolting, Simon Völkl
Publikováno v:
Immunity. 54:1772-1787.e9
As substantial constituents of the multiple myeloma (MM) microenvironment, pro-inflammatory macrophages have emerged as key promoters of disease progression, bone destruction, and immune impairment. We identify beta-2-microglobulin (β2m) as a driver
Autor:
Daniel Hofbauer, Savita Bisht, Robert Zeiser, Jens Nolting, Heiko Bruns, Shaima’a Hamarsheh, Dimitrios Mougiakakos, Andreas Mackensen, Frank Neumann, Stefano Ricagno, Maike Büttner-Herold, Katrin Bitterer, Martin Boettcher, Martin Eberhardt, Mario M. Zaiss
Publikováno v:
Blood. 134:2314-2314
Multiple myeloma (MM) is closely dependent on cross-talk between malignant plasma cells and cellular components of the inflammatory bone marrow milieu, which promotes disease progression, bone destruction and immune-impairment. However, the molecular
Autor:
Tilman Brummer, Shaima’a Hamarsheh, Olaf Groß, Claudia Lengerke, Oliver Gorka, Lena Osswald, Justus Duyster, Melanie Börries, Miriam Erlacher, Robert Zeiser
Publikováno v:
Blood. 132:2618-2618
Oncogenic Ras mutations occur frequently in myelodysplastic (MDS) and myeloproliferative syndromes (MPN). It was unclear if besides the direct transforming effect via constant RAS/MEK/ERK signaling, an inflammation related effect of KRAS contributes